Tineco's Modern Living Vision Earns Global Media Recognition at CES 2026

Thoughtful design and intelligent performance helped position Tineco among the most recognized brands at CES 2026

SEATTLE, Jan. 13, 2026 /PRNewswire/ -- CES 2026 marked an important milestone for Tineco, as the brand's Modern Living vision resonated with global media, industry experts, and the CES audience. Showcasing thoughtfully engineered floor care solutions within immersive, home-inspired environments, Tineco emerged from the show with multiple prestigious media awards, reinforcing its position as a brand redefining how intelligent cleaning integrates into modern homes.

Rather than presenting products in isolation, Tineco reimagined the CES experience as a series of contemporary living spaces — spaces where technology supports everyday routines through purposeful design, intuitive performance, and refined aesthetics. This approach not only redefined how visitors engaged with smart floor care, but also earned widespread recognition from leading international media throughout the show.

Media Recognition Highlights from CES 2026

FLOOR ONE S9 Scientist

As the most awarded product in Tineco's CES 2026 portfolio, the FLOOR ONE S9 Scientist was recognized for its advanced intelligence, deep-cleaning performance, and highly refined user experience. Media and reviewers highlighted its ability to automatically adapt to different messes while delivering powerful, precise results in real-life scenarios.

• thekitchn Best in Show 2026
• Trusted Reviews Innovation Award CES 2026
• Digital Trends Publisher Awards CES 2026 Winner
• Reviewed CES Awards 2026
• InsideDigital & nextpit Community's Choice Award 2026 – Best Product Nominee
• GADGETY Awards Best of Showstoppers CES 2026
• MAXIM Best of CES 2026

FLOOR ONE Station S9 Artist

Celebrated for blending elevated aesthetics with high-performance floor care, the S9 Artist stood out among design-forward media for transforming routine cleaning into a seamless, quiet, and visually refined experience. Its integrated Smart Refresh Station and effortless maintenance system were widely praised for fitting naturally into modern homes.

• GADGETY Awards Best of Showstoppers CES 2026
• InsideDigital & nextpit Community's Choice Award 2026 – Best Product Nominee

FLOOR ONE i7 Fold

Designed for compact, urban lifestyles, the FLOOR ONE i7 Fold earned recognition for its lightweight construction, foldable design, and ability to deliver full cleaning performance in space-conscious environments. Media highlighted its practicality for modern apartments and busy, urban lifestyles without sacrificing capability.

• GADGETY Awards Best of Showstoppers CES 2026
• MAXIM Best of CES 2026
• ComputerBild CES Highlight 2026

FLOOR ONE S9 Master

Positioned as the flagship of modern luxury floor care, the S9 Master was recognized for its premium build, advanced visibility features, and responsive guidance system. Reviewers noted its balance of powerful performance and intentional design, setting a new standard for high-end home cleaning.

• MAXIM Best of CES 2026

"These recognitions are meaningful because they come from how our products are experienced, not just how they perform on paper," said Mr. Leng, CEO of Tineco. "CES 2026 showed that when thoughtful engineering meets intentional design, cleaning technology becomes something people genuinely want to live with."

With a global community of over 23 million users, Tineco continues to evolve beyond traditional home appliances, reflecting its evolution into a modern living brand that understands how people live, move, and care for their spaces today. The recognition earned at CES 2026 reflects growing confidence from both media and consumers in this direction.

As Tineco looks ahead, the momentum from CES 2026 will continue to guide product innovation and brand storytelling — always centered on creating intelligent solutions that feel natural, dependable, and beautifully integrated into everyday life.

About Tineco
Tineco ("tin-co") was founded in 1998 with its first product being a vacuum cleaner and, in 2019, pioneered the first-ever smart vacuum. Today, the brand has evolved into a global leader in intelligent appliances spanning floor care, kitchen, and personal care categories. With a growing user base of over 23 million households and availability in approximately 30 countries worldwide, Tineco remains committed to its brand vision of making life easier through smart technology and continuous innovation. For more information, visit au.tineco.com.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Tineco's Modern Living Vision Earns Global Media Recognition at CES 2026

FREMONT, Calif., Jan. 13, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) NULISAqpcr™ AD 5-plex Assay. This innovative solution enables simultaneous quantitative measurement of five critical blood-based biomarkers relevant to the Alzheimer's Association recommended guidelines: brain-derived phosphorylated tau 217 (BD-pTau217), neurofilament light chain (NfL), amyloid-beta 42 (Aβ42), glial fibrillary acidic protein (GFAP), and APOE4 (carrier status), all from a single blood or plasma sample.

The NULISAqpcr AD 5-plex Assay consolidates key biomarkers into a single multiplexed format, delivering unmatched sensitivity, specificity, and ease of use. By incorporating BD-pTau217, Aβ42, NfL, and GFAP, the assay enables robust monitoring of amyloid and tau pathology, neurodegeneration, and inflammation, while accurately determining APOE4 carrier status—the strongest genetic risk factor for Alzheimer's disease. Together, these capabilities create a powerful tool for both translational and clinical research, and its relevance extends beyond Alzheimer's disease to other neurodegenerative and cognitive disorders.

"The launch of the NULISAqpcr AD 5-plex Assay marks a significant milestone in our efforts to deliver precision proteomics solutions for neurodegenerative disease," said Dr. Yuling Luo, founder, chairman and chief executive officer of Alamar. "By combining these critical protein targets into a single assay with a streamlined workflow, we are empowering the neuroscience community to advance screening, early detection and precision diagnoses for Alzheimer's disease."

"Blood-based biomarkers are redefining Alzheimer's research, providing an accurate, cheaper and more accessible means of establishing early diagnosis and aiding determination of eligibility for therapies," said Dr. Steven Williams, chief scientific officer of Alamar. "Traditional single-plex assays can measure these biomarkers individually, but require multiple tests to provide a comprehensive view of the disease. With NULISA™ it is now possible to measure multiple Alzheimer's-related proteins in blood, each offering unique insights into the underlying pathophysiology."

Alamar is dedicated to collaborating with researchers, clinicians, and industry partners to unlock precision proteomics and improve outcomes for patients affected by Alzheimer's disease and other neurodegenerative conditions. The NULISAqpcr AD 5-plex Assay is available today as a service through our Technology Access Program.

For more information about the NULISAqpcr AD 5-plex Assay and Alamar's full portfolio of precision proteomic solutions, visit www.alamarbio.com.

About Alamar Biosciences, Inc.

Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com. 

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research